Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Mizuho Sato-Dahlman"'
Autor:
Hideki Yoshida, Mizuho Sato-Dahlman, Praveensingh Hajeri, Kari Jacobsen, Lisa Koodie, Chikako Yanagiba, Ryan Shanley, Masato Yamamoto
Publikováno v:
Translational Oncology, Vol 14, Iss 2, Pp 100997- (2021)
The PAX3-FOXO1 fusion gene functions as a transactivator and increases expression of many cancer-related genes. These lead to metastases and other unfavorable outcomes for alveolar rhabdomyosarcoma (ARMS) patients. In order to target ARMS with the PA
Externí odkaz:
https://doaj.org/article/99f0d7a67fd34a6f99fb7832e972d8bf
Autor:
Margarita V. Romanenko, Rafael S. Andrade, Julia Davydova, Amanda O. Salzwedel, Christopher J. LaRocca, Masato Yamamoto, Mizuho Sato-Dahlman
Publikováno v:
Annals of Surgical Oncology. 28:8556-8564
Esophageal adenocarcinoma (EAC) has increased in incidence in Western countries, and its poor prognosis necessitates the development of novel therapeutics. We previously reported the potential of conditionally replicative adenoviruses (CRAd) as a nov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a0d2de2b37221ab7c57d1995dc5c44ad
https://doi.org/10.1245/s10434-021-10382-7
https://doi.org/10.1245/s10434-021-10382-7
Autor:
Keith Wirth, Shuhei Shinoda, Mizuho Sato-Dahlman, Deborah M. Dickey, David A. Bernlohr, Sayeed Ikramuddin, Masato Yamamoto
Publikováno v:
Surg Obes Relat Dis
Obesity and diabetes are associated with an increased incidence of pancreatic cancer. Fatty acid binding protein 4 (FABP4), noted to be higher in patients with severe obesity, is linked to the development and progression of several cancers, and its l
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ab4ef0075b972cef5c2d93e9eefcc202
https://pubmed.ncbi.nlm.nih.gov/35131198
https://pubmed.ncbi.nlm.nih.gov/35131198
Autor:
Lisa Koodie, Masato Yamamoto, Ryan Shanley, Kari Jacobsen, Praveensingh Hajeri, Mizuho Sato-Dahlman, Hideki Yoshida, Chikako Yanagiba
Publikováno v:
Translational Oncology
Translational Oncology, Vol 14, Iss 2, Pp 100997-(2021)
Translational Oncology, Vol 14, Iss 2, Pp 100997-(2021)
Highlights • Oncolytic adenovirus targeting a transactivator PAX3-FOXO1 was newly developed. • Promoter of MYOG can be a potential candidate for controlling adenovirus for RMS. • Mutation in MEF2 binding site enhances the specificity and safety
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e24b8a7c20fd8b69ccc9c7fd5f52f70
http://europepmc.org/articles/PMC7749408
http://europepmc.org/articles/PMC7749408
Autor:
Mizuho Sato-Dahlman, Masato Yamamoto, Christopher J. LaRocca, Rafael S. Andrade, Margarita V. Romanenko, Julia Davydova, Amanda O. Salzwedel
Publikováno v:
Annals of Surgical Oncology. 28:565-566
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::05a14e81464f0242f6cd458f67d4dfa5
https://doi.org/10.1245/s10434-021-10422-2
https://doi.org/10.1245/s10434-021-10422-2
Autor:
Christopher J, LaRocca, Amanda O, Salzwedel, Mizuho, Sato-Dahlman, Margarita V, Romanenko, Rafael, Andrade, Julia, Davydova, Masato, Yamamoto
Publikováno v:
Annals of surgical oncology. 28(13)
Esophageal adenocarcinoma (EAC) has increased in incidence in Western countries, and its poor prognosis necessitates the development of novel therapeutics. We previously reported the potential of conditionally replicative adenoviruses (CRAd) as a nov
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::86e821b844b2154ce8fc5219fea40a0d
https://pubmed.ncbi.nlm.nih.gov/34423401
https://pubmed.ncbi.nlm.nih.gov/34423401
Publikováno v:
Cancers, Vol 12, Iss 1295, p 1295 (2020)
Cancers
Cancers
Gene therapy with viral vectors has significantly advanced in the past few decades, with adenovirus being one of the most commonly employed vectors for cancer gene therapy. Adenovirus vectors can be divided into 2 groups: (1) replication-deficient vi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::334d95a4025442a04b1b6bead14c1b57
https://www.mdpi.com/2072-6694/12/5/1295
https://www.mdpi.com/2072-6694/12/5/1295
Autor:
Praveensingh Hajeri, Julia Davydova, Mizuho Sato-Dahlman, Jing Li Huang, Yoshiaki Miura, Kari Jacobsen, Masato Yamamoto
Publikováno v:
Oncotarget
// Mizuho Sato-Dahlman 1 , Yoshiaki Miura 1 , Jing Li Huang 1 , Praveensingh Hajeri 1 , Kari Jacobsen 1 , Julia Davydova 1, 2 and Masato Yamamoto 1, 2, 3 1 Department of Surgery, University of Minnesota, Minneapolis, Minnesota, USA 2 Masonic Cancer C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a668ca492c53e0465cb6ed3e3332958
http://europepmc.org/articles/PMC5652684
http://europepmc.org/articles/PMC5652684
Publikováno v:
Gastroenterology. 160:S-469
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f7bd644a9aa46eb2ec6f1dbd0fad565d
https://doi.org/10.1016/s0016-5085(21)01828-x
https://doi.org/10.1016/s0016-5085(21)01828-x
Autor:
Mizuho Sato-Dahlman, Masato Yamamoto
Publikováno v:
Cancer Research. 79:B62-B62
Adenovirus (OAd) has high potential for systemic cancer therapy. However, its efficacy upon systemic application has been quite limited to date. Unlike locoregional therapy, systemic application of cancer therapy mandates better tumor distribution an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a55860680e3d0a96a8f1fd3b1453e8ea
https://doi.org/10.1158/1538-7445.panca19-b62
https://doi.org/10.1158/1538-7445.panca19-b62